AHA GUIDELINES Bundle (free trial)

High Blood Pressure

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512419

Contents of this Issue

Navigation

Page 48 of 57

49 Adrenergic blockers (cont'd) Nonselective alpha receptor antagonist Phentolamine • IV bolus dose 5 mg. • Additional bolus doses every 10 min as needed to lower BP to target. • Used in hypertensive emergencies induced by catecholamine excess (pheochromocytoma, interactions between monamine oxidase inhibitors and other drugs or food, cocaine toxicity, amphetamine overdose, or clonidine withdrawal). Others Dopamine 1 - receptor selective agonist Fenoldopam • Initial 0.1–0.3 mcg/ kg/min. • May be increased in increments of 0.05–0.1 mcg/kg/ min every 15 min until target BP is reached. • Maximum infusion rate: 1.6 mcg/kg/ min. • Contraindicated in patients at risk of increased intraocular pressure (glaucoma) or intracranial pressure and those with sulfite allerg y. ACE inhibitor Enalaprilat • Initial 1.25 mg over a 5-min period. • Doses can be increased up to 5 mg every 6 h as needed to achieve BP target. • Contraindicated in pregnancy and should not be used in acute MI or bilateral renal artery stenosis. • Mainly useful in hypertensive emergencies associated with high plasma renin activity. • Dose not easily adjusted. • Relatively slow onset of action (15 min) and unpredictability of BP response. Table 15. Intravenous Antihypertensive Drugs for Treatment of Hypertensive Emergencies (cont'd) Class Drug(s) Usual Dose Range Comments

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - High Blood Pressure